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tively, and JSN; the 22 and 7 ml knee vols gave similar results 
(Table 1). Correlations increased using 0-111K-L grading. BSP and 
sclerosis were negatively correlated. Using just the knee with the 
worse K-L grade, only one correlation, 846 and JSN, was signifi- 
cant. 
Table 1. Pearson correlation coefficients 
TQOL variable Neo epitope 846 C-II ProP 
K-L 0-IV 0-111 K-L 0-IV 0-111 
K-L knee 22 ml 0.286 0.428 0.339 0.414 
K-L knee 7 ml 0.346 0.483* 0.439 0.508* 
JSN 22 ml 0.663** 0.663** 0.508* 0.508* 
JSN 7 ml 0.660** 0.660** 0.600** 0.600** 
* p < 0.05; **p < 0.01. 
Conclusions: Biomarkers require assessment with regard to the 
total body burden of OA. The positive correlations between mark- 
ers of cartilage synthesis seen in our younger study population 
are consistent with previously described increases in synthesis in 
early OA. Calculations based on multiple joints and relative car- 
tilage volume provide a more valid representation of biomarker 
activity. 
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Aim of Study: This study was conducted to evaluate the diurnal 
variation of serum and urine levels of the osteoarthritis-related 
biomarkers in participants with osteoarthritis (OA) of the knee. 
Methods: Twenty participants with radiographic OA of at least 
one knee were admitted to the General Clinical Research Center 
at Duke University Medical Center for an overnight stay for se- 
rial blood and urine sampling. The first blood sample (T3) was 
collected between 6:00 and 8:00 p.m. on the day of admission 
after a normal day of activity. During the night of bed rest, par- 
ticipants remained supine for a minimum of five hours between 
3:00 and 8:00 a.m. Blood was drawn prior to arising from bed 
(TO), and one hour (T1) and four hours (T2) after arising and 
performing their normal morning activities including eating break- 
fast. Serial urine samples were obtained from 14 of these partic- 
ipants. Serum hyaluronan (HA), cartilage oligomeric matrix pro- 
tein (COMP), and Keratin Sulfate (KS 5D4) were measured us- 
ing in-house ELISA methods as previously described. Serum C- 
reactive protein (CRP), Osteocalcin, TGF-I~I, and collagen II- 
related epitopes (C2C, C1,2C, CPII, and urinary CTX-II) were 
measured using commercially available ELISA kits. Results were 
analyzed using non-parametric Friedman's test with Dunn's post- 
hoc Multiple Comparison test. 
Results: Serum concentrations of HA, COME KS 5D4, TGF-I~I 
and CPII showed significant variation with morning activity. Mean 
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serum concentrations of HA, COME KS 5D4 and TGF-I~I in- 
creased significantly from TO, before arising from bed, to T1, one 
hour after arising (p<0.01, p<0.001, p<0.001, and p<0.01, re- 
spectively), while CPII increased significantly from TO to T2, after 
four hours of morning activities (p<0.01). No activity-related or 
diurnal variation was observed in other serum biomarkers, CRE 
Osteocalcin, C2C and C1,2C (p>0.05 for all time periods). In ad- 
dition, urinary levels of CTX-II, normalized to creatinine, were also 
found to vary with morning activity. Interestingly, in the case of the 
urinary CTX-II, the mean concentration decreased significantly 
from TO to T2, after four hours of morning activities (p=0.04). 
Conclusions: To our knowledge, this is the first study to evaluate 
diurnal variation of biomarkers in a cohort with radiographic knee 
OA. Our study suggests that serum sampling for COME KS and 
TGF-I~I should be performed more than one hour after arising 
from the bed and four hours after arising in the case of serum 
CPII and urinary CTX-II in future OA clinical trials. 
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AIM: To determine the presence of anti- CCP antibodies, COME 
RF and CRP in a group of well-characterized patients with erosive 
hand OA. 
Methods: Patients were recruited from 2 centers (Richmond, VA 
and Wyomissing, PA) to assess the relationship of bone min- 
eral density to burden of hand arthritis in individuals with erosive 
and nonerosive hand OA. Physical exam and hand x-rays were 
used to characterize the differences. Proximal and distal interpha- 
langeal joints of all fingers, IPs of thumbs and 1 st CMC joints were 
used in joint counts (n=20). A blinded, musculoskeletal radiologist 
utilized the Kellgren Lawrence (K-L) score, as well as assessed 
for the presence of erosions typical of erosive OA. A joint was 
scored as having radiographic OA if the K-L score was _>2. A 
composite radiographic score from 0-80 was created for each in- 
dividual based on a K-L score of between 0-4 for each joint. Anti- 
CCP antibodies and COMP (in a subset of patients with available 
sera) were assayed using ELISA at RDL reference Laboratory 
(Los Angeles, California). RF and CRP were measured at the our 
institution. 
Results: A subgroup of thirty patients from the study was ana- 
lyzed (15 with erosive OA and 15 controls with nodal hand OA: 
13 women and 2 men in each group). Patients were age and sex 
matched, mean age for cases was 71.8(SD 7.48), and for con- 
trols was 72.4(SD 6.66). Subjects with erosive hand OA had a 
significantly higher number of joints involved (mean joint count of 
14.53 4- 3.6 vs. 6.24- 4.18) and a significantly higher composite 
of Diurnal Variation of Biomarkers in OA 
TO vs. T1 TO vs. T2 TO vs. T3 T1 vs. T2 T1 vs. T3 T2 vs. T3 
HA p < 0.01 (1") NS NS NS NS NS 
COMP p < 0.001 (I") p < 0.001 (I") p < 0.01 (I") NS NS NS 
KS 5D4 p < 0.001 (1") p < 0.05 (1") NS NS NS NS 
TGF-bl p < 0.01 (1") p < 0.01 (1") NS NS NS NS 
CPII NS p < 0.01 (I") NS NS NS NS 
uCTX-II NS p = 0.04 ($) p = 0.01 ($) p = 0.007 ($) NS NS 
NS = p > 0.05 
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radiographic score (mean joint score of 474-10.4 vs. 20.264-8.2). 
RF and anti- CCP antibodies were absent in all patients. There 
was a trend for higher CRP in cases (mean level of 0.905 mg/dl 
4- 1.35) compared to controls (mean level of 0.272 mg/d14-0.22). 
Of significance, there was a correlation of CRP with higher radio- 
graphic score (p of 0.071). Sera from 10 patients was evaluated 
for COME There was no difference in levels between cases and 
controls (cases 11.1 U/L4-4.13, controls 12.36U/L4- 1.38). 
Conclusion: Erosive hand OA may represent a distinct subset 
of OA. In spite of significant erosive disease in these individuals, 
both RF and anti- CCP antibodies were negative, corroborating 
recent findings. Further evaluation of COMP in this population, 
particularly accounting for the overall burden of OA, is warranted. 
The trend towards elevated CRP in the erosive hand OA suggests 
that this may represent a systemic inflammatory disorder. 
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Aim of the study: To determine Coil 2-1 level, a peptide of type II 
collagen triple helix, and its nitrated form (Coil 2-1 NO2) in serum 
of patients with knee or hip osteoarthritis (OA) before and three 
months after knee or hip replacement. 
Methods: Coil 2-1 and Coil 2-1 NO2 were measured by two 
specific competitive immunoassays in 35 healthy subjects and 
in 44 patients with knee or hip OA candidates for joint re- 
placement. Sera were taken the day before the surgery and 
three months after the hip or knee replacement. The immunoas- 
says were specific for a peptide of the helical region of type 
II collagen, l°SHRGYPGLDG116 (Coil 2-1), and its nitrated form 
1°SHRGY(NO2)PGLDG116 (Coil 2-1 NO2), respectively. 
Results: Before surgery, Coil 2-1 and Coil 2-1 NO2 levels were 
higher in serum of OA patients than in healthy subjects of the 
same range of age [Coil 2-1:175.30 4- 11.10 nM vs 133.11 4- 7.86 
nM (p<0.01) and Coil 2-1 NO2:0.94 4- 0.09 nM vs 0.49 4- 0.03 
nM (p< 0.001)]. Three months after hip or knee replacement, Coil 
2-1 concentration in serum of OA patients decreased below the 
level of the healthy subjects [86.99 4- 5.36 nM vs 133.11 4- 7.86 
nM (p<0.001)]. Moreover, a significant correlation between Coil 
2-1 levels in OA patients before and after hip or knee replacement 
has been found (r = 0.43, p=0.009). In contrast, Coil 2-1 NO2 
serum level did not vary after surgery (0.75 4- 0.05 nM). 
Conclusions: These findings suggest that Coil 2-1 and Coil 2- 
1 NO2 are interesting markers for detection of late structural 
change in OA patients. Furthermore, the decrease of Coil 2-1 
after surgery and the correlation between pre- and post-surgery 
serum levels of Coil 2-1 suggest that Coil 2-1 is a disease-specific 
marker. 
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Aim of Study: A major and early feature of cartilage degenera- 
tion is proteoglycan breakdown. MMP-13 plays an important role 
in osteoarthritic (OA) cartilage degradation. This MMP, in addition 
to initiating collagen fiber cleavage, also acts on several proteo- 
glycans. Among the proteoglycan families, one termed the small 
leucine-rich proteoglycans (SLRPs) was found to be involved in 
collagen fibril formation/interaction, with some members demon- 
strating a role in the OA process. We investigated the ability of 
MMP-13 to cleave members of two classes of SLRPs: 1) bigly- 
can and decorin and 2) fibromodulin and lumican. 
Methods: SLRPs were isolated from human normal and OA car- 
tilage using guanidinium chloride (4 M) extraction. Digestion prod- 
ucts were examined by Western blotting. The identity of the MMP- 
13 degradation products of biglycan (using specific substrate) 
was determined following electrophoresis and microsequencing. 
Results: We showed that the SLRPs studied were cleaved to dif- 
fering extents by human MMP-13. Although only minimal cleav- 
age of decorin and lumican was observed, cleavage of fibromod- 
ulin and biglycan was extensive, suggesting that both molecules 
are preferential substrates. In contrast to decorin, and lumican, 
which yielded a similar degradation pattern for both normal and 
OA, biglycan, but particularly fibromodulin, had a higher level of 
degradation with increased cartilage damage. Microsequencing 
revealed a novel major cleavage site (... VPK178-179VFS) for 
biglycan upon exposure to MMP-13. 
Conclusion: We showed, for the first time, the ability of MMP-13 
to degrade members from two classes of the SLRP family, and 
the site at which biglycan is cleaved by MMP-13. The MMP-13- 
induced SLRP degradation may represent an early critical event, 
which may in turn affect the collagen network by the exposure 
of the MMP-13 cleavage site in this macromolecule. Awareness 
of the SLRP degradation products, especially those of biglycan 
and fibromodulin, may assist in early detection of OA cartilage 
degradation. 
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Aim: Chondrocyte hypertrophy, a mediator of OA progression, is 
associated with an upregulation of the transglutaminases FXlIIA 
and transglutaminase 2 (TG2), so we examined the potential role 
of FXlIIA in promoting hypertrophy, an activity recently demon- 
strated for TG2. 
Methods: We employed RNAi knockdown of FXIIIA and TG2 
in cultured normal human knee articular chondrocytes. Primary 
knee chondrocytes also were isolated from TG2 +/+ and TG2- 
/- mice. Recombinant wild type FXlIIA and point mutants were 
generated to examine the need for the defined thrombin activa- 
tion and inactivation endoproteolytic sites, the transamidation cat- 
alytic site, the cation binding site, the isomerization site and the 
calcium binding domain. Bovine articular cartilage explants also 
were treated with recombinant TG2 and FXlIIA for examination of 
type X collagen expression. Finally, human articular chondrocytes 
were transfected and stimulated with recombinant TG2 and FXl- 
IIA to determine xtracellular TG2 levels by ELISA, expression of 
type X collagen and phosphorylation of p38 MAPK. 
Results: Recombinant wild type FXlIIA (100 ng/ml) induced 
chondrocyte hypertrophy, an activity dependent on both TG2 ex- 
pression and of TG2 externalization, as confirmed using TG2 -/- 
knee chondrocytes. FXlIIA did not act by directly binding or chap- 
